Skip to content

Newsroom

type
year
reltype
Illustration image.png

Inside information: Phase III ARANOTE trial of darolutamide in combination with androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer meets primary endpoint

7/17/2024 Stock exchange release
Illustration image.png

Inside information: Orion upgrades full-year outlook for 2024

7/1/2024 Stock exchange release
Illustration image.png

Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer

7/1/2024 Stock exchange release
Illustration image.png

Orion is developing the Finnish life science industry in a unique collaboration project

6/3/2024 Press release
Illustration image.png

Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025

5/7/2024 Stock exchange release
Illustration image.png

Orion Corporation: Managers’ transactions – Henrik Stenqvist

5/6/2024 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Veli-Matti Mattila

5/6/2024 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Hilpi Rautelin

5/6/2024 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Karen Lykke Sørensen

5/6/2024 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Ari Lehtoranta

5/6/2024 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Kari Jussi Aho

5/6/2024 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Maziar Mike Doustdar

5/6/2024 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Eija Ronkainen

5/6/2024 Managers transactions
Illustration image.png

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

4/26/2024 Flagging notifications
Illustration image.png

Composition of the Nomination Committee of Orion Corporation

4/26/2024 Stock exchange release
Illustration image.png

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

4/25/2024 Flagging notifications
Illustration image.png

Orion Group Interim Report January–March 2024

4/25/2024 Stock exchange release
Illustration image.png

Orion Corporation: Managers’ transactions – Veli-Matti Mattila

4/22/2024 Managers transactions